The SNS Densomere™ Platform for Controlled/Extended Drug Delivery
SNS technology shows one year In-Vivo bioactivity of macromolecules following a single administration.
Using a rabbit model, studies utilizing a corneal model indicate one year bioactivity in preventing angiogenesis with Avastin, and similar in-vitro results in other macromolecules.
Multiple Routes of Drug Delivery
SNS Can Engineer Particle Size
To inject microparticles, the largest particles must be < 1/3 of the inner diameter of the needle
E.g., to inject with a 27-gauge needle (inner diameter is 267 µm) particle size must be < 90 µm
SNS Densomeres can be engineered from nano to micro sizes